SHIP1 Modulators With Enhanced Water Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current SHIP1 modulators lack enhanced water solubility, limiting their therapeutic effectiveness in treating inflammatory and immune disorders, and there is a need for new compounds and methods to modulate SHIP1 activity effectively.
Innovation Solution
Development of small molecule SHIP1 modulators with enhanced water solubility, including specific compounds and methods for their synthesis and pharmaceutical compositions, to treat a wide range of disorders by modulating SHIP1 activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing SHIP1 modulators are used, then SHIP1 activity can be modulated, but water solubility is insufficient limiting therapeutic effectiveness
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of SHIP1 modulators through systematic variation of R1, R2, R3, R4, and R5 substituents (including hydroxyl, alkoxy, halogen, and amino groups) to optimize water solubility while maintaining SHIP1 modulation activity. This is achieved by changing polar and hydrophilic characteristics of the molecules.
Solution Approach 2:
The patent employs composite materials by combining different functional groups and molecular moieties within the SHIP1 modulator structures to create compounds with both high biological activity and enhanced water solubility. The composite nature of these molecules allows simultaneous optimization of solubility and pharmacological efficacy.
2Reliability
If water solubility is enhanced through molecular modification, then therapeutic effectiveness improves, but compound complexity increases
Solution Approach 1:
The patent systematically varies substituent parameters (R1-R5 groups) to achieve water solubility enhancement without excessive molecular complexity. By controlling the type and position of functional groups rather than dramatically increasing molecular size, the patent balances solubility improvement with structural simplicity.
Solution Approach 2:
The patent applies local quality by introducing hydrophilic functional groups at specific positions (R1, R2, R3, R4, R5) on the molecular structure rather than uniformly complicating the entire molecule. This localized modification approach enhances water solubility while maintaining overall structural elegance and synthetic accessibility.
Data Source
AI summary
Compounds of structure (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2 and A are as defined herein are disclosed. Such compounds have enhanced water solubility and have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Enantioselective methods for preparation of compounds of structure (I), compositions comprising a compound of structure (I) in combination with a pharmaceutically acceptable carrier or diluents and methods of SHIP1 modulation by administration of such compounds to an animal in need thereof are also disclosed.